Xeljanz side effects may increase the risk of pulmonary embolism by a factor of five when taken at higher doses, according to the preliminary findings of a clinical trial.…
Pfizer is suing Ajanta Pharma over plans to release a generic version of Xeljanz years before its patent protection is scheduled to run out.…
A new report finds that problems with breast implants were hidden for years by lax medical device injury reporting rules and lax enforcement.…
A new study links drugs like Humira, Enbrel and Remicade to an increased risk of permanent nerve damage.…
The FDA has approved Actemra for use in some children, despite concerns over heart problems, infections and other health risks.…
The FDA plans to hold an advisory committee hearing to address concerns over silicone breast implant health risks, which some say can cause a number of illnesses in women.…
A new study warns of a number of illnesses linked to breast implants, including melanoma and rheumatoid arthritis.…
A consumer watchdog group called on FDA advisors to recommend that the agency reject approval for a new Eli Lilly arthritis drug which some data indicates could increase the risk of blood clot-related injuries.…
Actemra side effects may cause more bleeding in rheumatoid arthritis patients during knee replacement surgery, a new study warns.…
A new study looking at the uses and side effects of Actemra, Enbrel and Rituxan suggests that observational studies may be a better predictor of drug effectiveness and safety than clinical trials.…
